Our data indicated that bladder cancer patients with high TstcSig exhibited “hot tumor” characteristics, characterized by a higher proportion of infiltrating immune cells, elevated immune scores, and increased expression of immune checkpoint genes such as PDCD1, CDLA4, LAG3, and CD274. This evidence concerns the gene PDCD1 and urinary bladder cancer.